Showing 1 - 10 of 32
Persistent link: https://www.econbiz.de/10001700734
Persistent link: https://www.econbiz.de/10011980353
There are two types of prescription drug cost offsets. The first type of cost offset - from prescription drug use - is primarily about the effect of changes in drug quantity (e.g. due to changes in out-of-pocket drug costs) on other medical costs. The second type of cost offset - the cost offset...
Persistent link: https://www.econbiz.de/10011987056
Persistent link: https://www.econbiz.de/10012239676
Persistent link: https://www.econbiz.de/10011859673
I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003–2013, by investigating whether there were larger declines in the age-standardized mortality rate of cancer sites (breast, lung, colon, etc.) that were subject to more pharmaceutical...
Persistent link: https://www.econbiz.de/10011885726
Persistent link: https://www.econbiz.de/10001966562
I investigate whether the types of cancer (breast, colon, lung, etc.) subject to greater penetration of new ideas had larger subsequent survival gains and mortality reductions, controlling for changing incidence. I use the MEDLINE/PubMED database, which contains more than 23 million references...
Persistent link: https://www.econbiz.de/10012480979
There are two types of prescription drug cost offsets. The first type of cost offset—from prescription drug use—is primarily about the effect of changes in drug quantity (e.g. due to changes in out-of-pocket drug costs) on other medical costs. The second type of cost offset—the cost offset...
Persistent link: https://www.econbiz.de/10012889758
We use data from PubMed and other sources to examine the impact of public and private research support on premature (before ages 75, 65, and 55) cancer mortality and hospitalization, by estimating difference-in-differences models based on longitudinal, cancer-site-level data on about 30 cancer...
Persistent link: https://www.econbiz.de/10012960774